Chronic lymphocytic leukaemia and Rheumatoid arthritis

The association between chronic lymphocytic leukaemia and rheumatoid arthritis has been confirmed in some cases. Rheumatoid arthritis is a chronic autoimmune inflammatory disease characterized by erosive arthritis of the joints.
Chronic lymphocytic leukaemia is a clonal malignancy of lymphocytes, which is manifested by immunosuppression, bone marrow failure, and organ infiltration with neoplastic cells.

Showing all 8 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price
Rituximab H0209B04	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	09/2018	217,00 €	view product Max: 10 Min: 1 Step: 1
Rituximab N7129B16	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	12/2018	217,00 €	view product Max: 10 Min: 1 Step: 1
Rituximab N7135B11	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	02/2019	217,00 €	view product Max: 10 Min: 1 Step: 1
Rituximab N7135B18	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	02/2019	217,00 €	view product Max: 10 Min: 1 Step: 1
Rituximab N7174B06	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	08/2019	217,00 €	view product Max: 10 Min: 1 Step: 1
Rituximab N7190B08	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	12/2019	217,00 €	view product Max: 10 Min: 1 Step: 1
Rituximab N7321B38	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	07/2021	250,00 €	view product Max: 10 Min: 1 Step: 1
Rituximab N7438B09	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	yes	2 mg	2-8°C / -80°C	02/2023	217,00 €	view product Max: 10 Min: 1 Step: 1

Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin

+49 (0) 30 959 99 8831 info@evidentic.com